Lobster hemolymph as a utility for the treatment of mammalian tissue lesions

Abstract

The invention is crustacean hemolymph as a utility for the pharmaceutical and/or cosmetic treatment of viral and other neoplastic or pre-neoplastic mammalian tissue lesions. The method comprises topically administering to mammalian tissue a formula that is made from lobster hemolymph—neat; or lobster hemolymph extracts; or lobster hemolyph in combination with certain carriers, binders; or as an adjuvant. The hemolymph may be from various species of lobster, Homarus americanus in particular.

We claim: 
     
         1 . A method of treating a pre-neoplastic skin lesion comprising administering to a mammalian skin epidermis a topical formula that comprises lobster hemolymph, wherein the lobster hemolymph is extracted from one or more of  Homarus americanus, Homarus gammarus , or  Panulirus argus.    
     
     
         2 . A method as claimed in  claim 1 , wherein the hemolymph is neat. 
     
     
         3 . A method as claimed in  claim 2 , wherein the hemolymph is extracted by piercing the pericardial membrane of  Homarus americanus  and drawing hemolymph into an attached syringe. 
     
     
         4 . A method as claimed in  claim 2 , wherein the hemolymph is extracted by lancing the soft tissue of  Homarus americanus  to allow hemolymph to flow into a catch basin or bottle. 
     
     
         5 . A method as claimed in  claim 2 , wherein the hemolymph is extracted by separating the thorax from the abdomen of  Homarus americanus  to open the circulatory system and allow hemolymph to drain into a catch basin or bottle. 
     
     
         6 . A method as claimed in  claim 2 , wherein the hemolymph is extracted by piercing the pericardial membrane of  Homarus gammarus  and drawing hemolymph into an attached syringe. 
     
     
         7 . A method as claimed in  claim 2 , wherein the hemolymph is extracted by lancing the soft tissue of  Homarus gammarus  to allow hemolymph to flow into a catch basin or bottle. 
     
     
         8 . A method as claimed in  claim 2 , wherein the hemolymph is extracted by separating the thorax from the abdomen of  Homarus gammarus  to open the circulatory system and allow hemolymph to drain into a catch basin or bottle. 
     
     
         9 . A method as claimed in  claim 2 , wherein the hemolymph is extracted by piercing the pericardial membrane of  Panulirus argus  and drawing hemolymph into an attached syringe. 
     
     
         10 . A method as claimed in  claim 2 , wherein the hemolymph is extracted by lancing the soft tissue of  Panulirus argus  to allow hemolymph to flow into a catch basin or bottle. 
     
     
         11 . A method as claimed in  claim 2 , wherein the hemolymph is extracted by separating the thorax from the abdomen of  Panulirus argus  to open the circulatory system and allow hemolymph to drain into a catch basin or bottle. 
     
     
         12 . A method as claimed in  claim 1 , wherein the hemolymph is an active ingredient combined with unspecified binders or carriers. 
     
     
         13 . A method as claimed in  claim 1 , wherein the hemolymph is used as an adjuvant to existing prophylactic and/or cosmetic treatments of pre-neoplastic skin lesions, by topical administration to mammalian epidermis.